Fundz

AudioCure Pharma raised an undisclosed amount in a funding round led by InfectoPharm to advance the clinical development of the innovative drug candidate AC102 for sudden hearing loss.

PRIVATEFeb 13, 2025

Round Type

Funding Round

BerlinBiotechnologyHealth CareMedical

Investors

InfectoPharmMed ElHigh Tech Gründerfonds

Description

AudioCure Pharma, a Berlin-based start-up, secures new funding from InfectoPharm to support the development of AC102, a promising drug candidate for sudden hearing loss. The collaboration aims to enhance the clinical development and leverage the expertise of existing investors MED-EL and High-Tech Gründerfonds.

Quick answer

AudioCure Pharma raised an undisclosed amount in a Funding Round round, dated February 13, 2025. Investors: InfectoPharm, Med El and High Tech Gründerfonds. AudioCure Pharma is based in Berlin, Berlin, Germany.

How much did AudioCure Pharma raise?
AudioCure Pharma raised an undisclosed amount in a Funding Round round on February 13, 2025.
Who invested in AudioCure Pharma?
InfectoPharm, Med El and High Tech Gründerfonds are named as investors in this round.
What does AudioCure Pharma do?
AudioCure Pharma is a Berlin-based start-up focused on developing innovative treatments for sudden hearing loss.
Where is AudioCure Pharma based and how big is it?
AudioCure Pharma is based in Berlin, Berlin, Germany. Fundz records about 14 employees.
Who are the decision-makers at AudioCure Pharma?
Fundz holds 2 contacts at AudioCure Pharma. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Biotechnology around the same time

Companies in the same sectors as AudioCure Pharma that raised within 45 days of this round, from Fundz verified event records.

  • NeOnc Technologies raised $1.6M (Seed) on March 26, 2025.
  • Tenon Medical raised $1.5M on March 25, 2025.
  • Evident Vascular raised an undisclosed amount (Series B) on March 25, 2025.
  • Tenon Medical raised $2.5M on March 25, 2025.
  • Stride raised an undisclosed amount (Series A) on March 24, 2025.
  • Innventure raised $29M on March 24, 2025.

Who to call at AudioCure Pharma, and when

A new round usually means AudioCure Pharma is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day AudioCure Pharma raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at AudioCure Pharma, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at AudioCure Pharma. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

AudioCure Pharma

Location

Berlin, Berlin, Germany

About

AudioCure Pharma is a Berlin-based start-up focused on developing innovative treatments for sudden hearing loss. The company is currently conducting a Phase 2 clinical trial to test the efficacy of its new compound, AC102. This compound aims to address the unmet medical needs associated with sudden hearing loss, an area characterized by a lack of effective therapies. AudioCure Pharma aspires to achieve a paradigm shift in treatment options for this condition.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment AudioCure Pharma raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

2 contacts
Predictive Intelligence
Strategic

ML-powered predictions for AudioCure Pharma's next move

See what Strategic adds

AudioCure Pharma raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.